Literature DB >> 19067121

Time course of thrombosis and fibrinolysis in total knee arthroplasty with tourniquet application. Local versus systemic activations.

Olav Reikerås1, Torkil Clementsen.   

Abstract

BACKGROUND: Venous thrombosis is common in knee surgery, and it has been assumed that vein occlusion by tourniquet in itself may induce thrombogenic and fibrinolytic activity. Prophylactic treatment is used up to 12 h before or after surgery, and recent clinical trials suggest that the timing of initiating prophylaxis significantly influences antithrombotic effectiveness.
MATERIALS AND METHODS: We studied the time course of coagulation and fibrinolysis locally and systemically during total knee arthroplasty. Specific markers of thrombosis (prothrombin fragment 1.2 (F1.2)) and fibrinolysis (plasmin-antiplasmin (PAP) and D-dimer) were examined in seven female and two male patients.
RESULTS: There were no systemic activations of either F1.2 (P = 0.314), PAP (P = 0.314) or D-dimer (P = 0.600) during surgery or at 10 min postoperatively (P = 0.139, 0.139 and 0.128, respectively) as compared to baseline data. At 4 h postoperatively there were significant increments in levels of F1.2 (P = 0.008), PAP (P = 0.038) and D-dimer (P = 0.046). With tourniquet deflation the values of F1.2, PAP and D-dimer were significantly higher in the tourniquet limb than the in the contra lateral limb (P = 0.025, 0.012 and 0.028, respectively). At 10 min after tourniquet deflation, the differences in F1.2, PAP and D-dimer between the two limbs were not significant.
CONCLUSION: The use of tourniquet in total knee arthroplasty causes local thrombogenic and fibrinolytic activity, but without influences in the systemic circulation. Systemic activations in thrombosis and fibrinolysis start when local mediators from the injured limb are released after tourniquet deflation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19067121     DOI: 10.1007/s11239-008-0299-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  26 in total

Review 1.  Prevention of venous thromboembolism.

Authors:  W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin)

Authors:  O E Dahl; G Andreassen; T Aspelin; C Müller; P Mathiesen; S Nyhus; M Abdelnoor; J H Solhaug; H Arnesen
Journal:  Thromb Haemost       Date:  1997-01       Impact factor: 5.249

3.  Changes in coagulation-fibrinolysis marker and neutrophil elastase following the use of tourniquet during total knee arthroplasty and the influence of neutrophil elastase on thromboembolism.

Authors:  S Katsumata; M Nagashima; K Kato; A Tachihara; K Wauke; S Saito; E Jin; O Kawanami; R Ogawa; S Yoshino
Journal:  Acta Anaesthesiol Scand       Date:  2005-04       Impact factor: 2.105

4.  Prevention of fatal postoperative thromboembolism by heparin prophylaxis.

Authors:  J G Sharnoff; G DeBlasio
Journal:  Lancet       Date:  1970-11-14       Impact factor: 79.321

5.  Thromboembolic disease prophylaxis in total knee arthroplasty using intraoperative heparin and postoperative pneumatic foot compression.

Authors:  G H Westrich; A Menezes; N Sharrock; T P Sculco
Journal:  J Arthroplasty       Date:  1999-09       Impact factor: 4.757

6.  Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.

Authors:  M N Levine; J Hirsh; M Gent; A G Turpie; J Leclerc; P J Powers; R M Jay; J Neemeh
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

7.  A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.

Authors:  A G Turpie; M N Levine; J Hirsh; C J Carter; R M Jay; P J Powers; M Andrew; R D Hull; M Gent
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

8.  The role of bone traumatization in the initiation of proximal deep vein thrombosis during cemented hip replacement surgery in pigs.

Authors:  O E Dahl; T Aspelin; T Lyberg
Journal:  Blood Coagul Fibrinolysis       Date:  1995-12       Impact factor: 1.276

9.  Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.

Authors:  C W Colwell; T E Spiro; A A Trowbridge; B A Morris; H C Kwaan; J D Blaha; A J Comerota; V A Skoutakis
Journal:  J Bone Joint Surg Am       Date:  1994-01       Impact factor: 5.284

10.  Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement.

Authors:  R D Hull; R F Brant; G F Pineo; P D Stein; G E Raskob; K A Valentine
Journal:  Arch Intern Med       Date:  1999-01-25
View more
  13 in total

1.  The influence of a half-course tourniquet strategy on peri-operative blood loss and early functional recovery in primary total knee arthroplasty.

Authors:  Sen Chen; JianPing Li; Hao Peng; Jianlin Zhou; Hongsong Fang; Huifeng Zheng
Journal:  Int Orthop       Date:  2013-11-21       Impact factor: 3.075

2.  Does limb preconditioning reduce pain after total knee arthroplasty? A randomized, double-blind study.

Authors:  Stavros G Memtsoudis; Ottokar Stundner; Daniel Yoo; Alejandro Gonzalez Della Valle; Friedrich Boettner; Anna Maria Bombardieri; Kethy Jules-Elysee; Lazaros Poultsides; Yan Ma; Thomas P Sculco
Journal:  Clin Orthop Relat Res       Date:  2014-05       Impact factor: 4.176

Review 3.  The effect of tourniquet use in total knee arthroplasty: grading the evidence through an updated meta-analysis of randomized, controlled trials.

Authors:  Xu Li; Lu Yin; Zhao-Yu Chen; Lian Zhu; Hai-Li Wang; Wei Chen; Guang Yang; Ying-Ze Zhang
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-07-11

Review 4.  Tourniquet use in total knee arthroplasty: a meta-analysis.

Authors:  Ta-Wei Tai; Chii-Jeng Lin; I-Ming Jou; Chih-Wei Chang; Kuo-An Lai; Chyun-Yu Yang
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-12-15       Impact factor: 4.342

5.  Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial.

Authors:  Paphon Sa-Ngasoongsong; Thanaphot Channoom; Viroj Kawinwonggowit; Patarawan Woratanarat; Pongsthorn Chanplakorn; Bussanee Wibulpolprasert; Siwadol Wongsak; Umaporn Udomsubpayakul; Supaporn Wechmongkolgorn; Nantaporn Lekpittaya
Journal:  Orthop Rev (Pavia)       Date:  2011-06-29

Review 6.  Tourniquet application during anesthesia: "What we need to know?"

Authors:  Kamal Kumar; Craig Railton; Qutaiba Tawfic
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Oct-Dec

7.  Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.

Authors:  Jun-Feng Li; Hang Li; Hui Zhao; Jun Wang; Shen Liu; Yang Song; Hong-Fen Wu
Journal:  J Orthop Surg Res       Date:  2017-02-02       Impact factor: 2.359

8.  Comparison of Enoxaparin and Rivaroxaban in Balance of Anti-Fibrinolysis and Anticoagulation Following Primary Total Knee Replacement: A Pilot Study.

Authors:  Jinwei Xie; Jun Ma; Qiang Huang; Chen Yue; Fuxing Pei
Journal:  Med Sci Monit       Date:  2017-02-08

9.  A comparison of thrombosis in total knee arthroplasty with and without a tourniquet: a meta-analysis of randomized controlled trials.

Authors:  Jia Xie; Hao Yu; Fangyuan Wang; Juehua Jing; Jun Li
Journal:  J Orthop Surg Res       Date:  2021-06-25       Impact factor: 2.359

10.  Release of the tourniquet immediately after the implantation of the components reduces the incidence of deep vein thrombosis after primary total knee arthroplasty.

Authors:  P Zan; M O Mol; J J Yao; L Fan; D Yang; K Liu; G Li
Journal:  Bone Joint Res       Date:  2017-09       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.